Search filters

Combined use of tofacitinib (pan-JAK inhibitor) and ruxolitinib (a JAK1/2 inhibitor) for refractory T-cell prolymphocytic leukemia (T-PLL) with a JAK3 mutation

Image Image of a generic work. The text above it indicates that there is no free image of the work available, and that if you own one, you can click on the placeholder link to upload it.
Description scientific article published on 18 April 2019
Author/s

author: Koen van Besien  Mike Wei  Giorgio Inghirami  Elizabeth Margolskee  Steven M Horwitz  Alexandra Gomez-Arteaga 

Publication date April 18, 2019
Language
Country of origin
Wikipedia link
Copyright status
Missing/wrong data? Edit Wikidata item